SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-18-000035
Filing Date
2018-01-31
Accepted
2018-01-31 16:37:39
Documents
3
Period of Report
2018-01-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kconsobmonthly20172018x.htm 8-K 40345
2 EXHIBIT 99.1 ex991consobmonthly201712.htm EX-99.1 42099
3 ctilogoa34.jpg GRAPHIC 5054
  Complete submission text file 0000891293-18-000035.txt   90794
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 18563233
SIC: 2834 Pharmaceutical Preparations